List Title | APhA DrugInfoLine

Neurology

SORT BY: Most Recent Most Viewed

April 1, 2013

Generic meds: Changes in tablet, capsule color at refill linked to nonadherence

READ

PREVIEW
In a case-control study of patients receiving anti-epileptic drugs (AEDs), changes in the color of the AED tablet or capsule supplied at refill was associated with increased odds for...
January 29, 2013

Alemtuzumab for multiple sclerosis: Effective, but at what cost?

READ

PREVIEW

Alemtuzumab (Campath—Genzyme) lowered relapse rates more effectively than interferon beta-1a (Rebif—EMD Serono) in individuals with relapsing–remitting multiple sclerosis, according...
November 27, 2012

More than just numbers: Managing BP in acute ischemic stroke

READ

PREVIEW
An analysis of the Acute Stroke Registry and Analysis of Lausanne (ASTRAL) registry data suggest that baseline blood pressure (BP) and subsequent changes in BP in patients with an acute lacunar...
October 9, 2012

Forget about it: Ginkgo fails to decrease Alzheimer’s risk

READ

PREVIEW
In patients at least 70 years of age or older who reported memory complaints, taking standardized ginkgo biloba extract twice daily for 5 years did not decrease the risk of being diagnosed with...
August 7, 2012

Antiepileptic drugs increase risk of falls, fractures

READ

PREVIEW
Patients taking antiepileptic drugs (AEDs) were more likely to have osteoporosis or a fracture of the spine, clavicle, or ankle than matched control patients, according to a recent study. The...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.